$ABBV Recent News AbbVie's stock rallies 1.8%, leads

New Post Public Reply Private Reply Replies (0) Message Board

Dec 24, 2014 at 9:42 AM

$ABBV Recent News

AbbVie's stock rallies 1.8%, leads S&P 500 gainers 8 min ago - Tomi Kilgore
Health-care sector taking a broad beating as pricing fears grow 2:39 p.m. Dec. 23, 2014 - Tomi Kilgore
Steelcase shares slide as revenue comes in light 5:42 p.m. Dec. 22, 2014 - MarketWatch
S&P 500, Dow industrials close at records 4:41 p.m. Dec. 22, 2014 - Sara Sjolin
Stock market may wish investors a wary Christmas 8:19 a.m. Dec. 22, 2014 - Shawn Langlois
Express Scripts picks AbbVie over Gilead for hepatitis C drug 7:45 a.m. Dec. 22, 2014 - Joseph Walker
FDA approves AbbVie’s hepatitis treatment 3:33 p.m. Dec. 19, 2014 - Peter Loftus
AbbVie's stock gains 0.8% after FDA approval of hepatitis C treatment 3:21 p.m. Dec. 19, 2014 - Tomi Kilgore
Which stocks the billionaires are buying — and selling 1:32 p.m. Dec. 12, 2014 - The Trading Deck
Paulson takes stake in Abbvie, adds to Shire holdings 6:46 p.m. Nov. 14, 2014 - MarketWatch
Obama considering Lazard banker for Treasury post 4:20 p.m. Nov. 12, 2014 - Victoria McGrane
77 stocks in the S&P 500 Index rise to new highs 10:50 a.m. Nov. 12, 2014 - Philip van Doorn
Merck, Dendreon miss out on health-care rally 12:39 p.m. Nov. 10, 2014 - Russ Britt
S&P 500, Dow close at record levels 4:16 p.m. Oct. 31, 2014 - Barbara Kollmeyer
Apple rallies to record high; LinkedIn jumps 11:05 a.m. Oct. 31, 2014 - Sue Chang
AbbVie stock up 3.6% at $63.38 9:32 a.m. Oct. 31, 2014 - Ciara Linnane
AbbVie shares up 4% in premarket trade 8:52 a.m. Oct. 31, 2014 - Ciara Linnane
AbbVie raises outlook as profit, sales beat 8:26 a.m. Oct. 31, 2014 - MarketWatch.com
AbbVie shares up 2% as profit, sales beat estimates 8:00 a.m. Oct. 31, 2014 - Ciara Linnane
AbbVie prior FY EPS outlook was $3.06 to $3.16 7:54 a.m. Oct. 31, 2014 - Ciara Linnane

Gilead, Abbvie, Express Scripts, And Biotech Industry Turmoil Seen By Market-Makers 9 min ago - Seeking Alpha
Gilead Feels The Heat Of Competition 7:59 a.m. Today - Seeking Alpha
Dow Tops 18000 7:50 p.m. Dec. 23, 2014 - The Wall Street Journal Interactive Edition
Express Scripts (ESRX) Picks AbbVie's Hepatitis C Drug - Analyst Blog 4:50 p.m. Dec. 23, 2014 - Zacks.com
AbbVie Puts The Hurt On Gilead Sciences, Closes Exclusive Deal With Express Scripts 4:41 p.m. Dec. 23, 2014 - Seeking Alpha
Dow Reaches Record Close as Santa Claus Rally Hits Day 5 4:04 p.m. Dec. 23, 2014 - TheStreet.com
Investors Should Stay Long Stocks as Market Continues Hitting Highs 3:01 p.m. Dec. 23, 2014 - TheStreet.com
Dow, S&P 500 Near Session Highs After GDP Growth Smashes Expectations 2:25 p.m. Dec. 23, 2014 - TheStreet.com
Gilead Sciences Plunges for Second Day In A Row: What Wall Street's Saying 1:48 p.m. Dec. 23, 2014 - TheStreet.com
Gilead Falls on AbbVie and Express Scripts Deal: 3 Biotech ETFs to Watch - ETF News And Commentary 12:02 p.m. Dec. 23, 2014 - Zacks.com
Dow Industrials Top 18,000 but Biopharma Stocks Drag Nasdaq Lower 11:29 a.m. Dec. 23, 2014 - TheStreet.com
AbbVie (ABBV): Stock With Unusual Social Activity 11:21 a.m. Dec. 23, 2014 - TheStreet.com
Analysts Predict Big Value Trap for Gilead Investors 11:20 a.m. Dec. 23, 2014 - 247WallSt.com
Dow Crosses 18,000 for First Time on GDP Surge 11:06 a.m. Dec. 23, 2014 - InvestorPlace.com
Gilead Sciences Is Not a Buy; It's Heading Lower on Price War: Jim Cramer 11:01 a.m. Dec. 23, 2014 - TheStreet.com
Enanta Is The Big Winner In The Hepatitis C War Between Abbvie And Gilead 8:47 a.m. Dec. 23, 2014 - Seeking Alpha
AbbVie HCV combo med cleared in Canada 7:58 a.m. Dec. 23, 2014 - Seeking Alpha
AbbVie Competes On Price 7:58 a.m. Dec. 23, 2014 - Seeking Alpha
Gilead Sciences: Buy On The Drop? 7:35 a.m. Dec. 23, 2014 - Seeking Alpha
Who Is The Devil? Will Gilead Fall Or Soar In 2015? 7:27 a.m. Dec. 23, 2014 - Seeking Alpha

Pharmaceuticals, Medicines, Supplements and Drug Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 325400 8:15 a.m. Dec. 23, 2014 - PR Newswire - PRF
AbbVie to Present at Goldman Sachs Healthcare CEOs Unscripted Conference 8:00 a.m. Dec. 23, 2014 - PR Newswire - PRF
Pharma Deals Watch: Coverage Initiated on AstraZeneca, Advaxis, Radius Health, Cubist and AbbVie 9:00 a.m. Dec. 22, 2014 - PR Newswire - PRF
Express Scripts and AbbVie Make Hepatitis C Cure Available to Millions of Patients in Need 7:00 a.m. Dec. 22, 2014 - PR Newswire - PRF
Technical Data on Pharma Stocks - Pfizer, Merck, AbbVie, Akorn, and The Medicines 9:10 a.m. Dec. 12, 2014 - PR Newswire - PRF
AbbVie Presents Results from Phase 2 Study of Investigational Compound Venetoclax (ABT-199/GDC-0199) in Acute Myelogenous Leukemia at the 56th American Society of Hematology Annual Meeting 8:15 p.m. Dec. 7, 2014 - PR Newswire - PRF
Gardy & Notis LLP Issues Notice Of The Filing Of A Securities Class Action Against AbbVie And Its Chief Executive Officer 4:00 p.m. Nov. 26, 2014 - PR Newswire - PRF
CHMP Grants Positive Opinions of AbbVie's VIEKIRAX™ (ombitasvir/paritaprevir/ritonavir) + EXVIERA™ (dasabuvir) for the Treatment of Chronic Hepatitis C in Europe 8:00 a.m. Nov. 21, 2014 - PR Newswire - PRF
AbbVie to Present at Jefferies 2014 Global Healthcare Conference 7:00 a.m. Nov. 17, 2014 - PR Newswire - PRF
AbbVie Presents Results from Study of ABT-414 in Patients with Glioblastoma Multiforme at the 19th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology 4:48 p.m. Nov. 14, 2014 - PR Newswire - PRF
AbbVie to Present Results from Studies in Chronic Hepatitis C Patients with HIV-1 Co-Infection (TURQUOISE-I) and Liver Transplant Recipients (CORAL-I) at The Liver Meeting® 2014 9:00 a.m. Nov. 11, 2014 - PR Newswire - PRF
AbbVie to Present Results from Phase 2 PEARL-I Study in Genotype 4 Chronic Hepatitis C Patients at The Liver Meeting® 2014 8:00 a.m. Nov. 11, 2014 - PR Newswire - PRF
Infinity Reports Third Quarter 2014 Financial Results and Provides Company Update 4:01 p.m. Nov. 6, 2014 - BusinessWire - BZX
Technical Notes Covering Pharma Equities - AbbVie, Bristol-Myers Squibb, GlaxoSmithKline, Eli Lilly, and Teva Pharma Industries 8:50 a.m. Nov. 6, 2014 - PR Newswire - PRF
ABBVIE (ABBV) SHAREHOLDER ALERT – Andrews & Springer LLC Is Investigating AbbVie Inc. For Potential Securities Fraud and Breach of Fiduciary Duty 8:03 a.m. Nov. 5, 2014 - BusinessWire - BZX
AbbVie to Present at Credit Suisse 2014 Healthcare Conference 8:00 a.m. Nov. 5, 2014 - PR Newswire - PRF
ABBVIE INC. ALERT -- Andrews & Springer LLC is Investigating AbbVie Inc. for Potential Securities Fraud and Breach of Fiduciary Duty 8:09 a.m. Nov. 3, 2014 - GlobeNewswire
Myriad and AbbVie Sign Expanded Agreement for Tumor BRACAnalysis CDx(TM) 7:05 a.m. Nov. 3, 2014 - GlobeNewswire
CMK Select Recognized as Women's Business Enterprise 10:45 a.m. Oct. 31, 2014 - Marketwired
AbbVie Reports Third-Quarter 2014 Financial Results 7:49 a.m. Oct. 31, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Govee's Retro Holiday Lights: A Festive Nostalgia Trip

Ah, the holidays—they're creeping up like a kid sneaking downstairs for a peek at their gifts. But it's not the gifts under the tree that brighten a room, it's those lights draping the tree itself. Enter Govee, bringing us back to that vintage glow we all remember from our childhoods. They've teamed up with Brady Tolbert, a design whiz who can make a living room look...

Artprice Champions Creative Freedom with AI in 2026

AI and the Creative Reawakening As the autumn of 2026 rolls in, publishing circles are buzzing over artificial intelligence's role in artistry. Weekly updates hailing rejection, tolerance, or adaptation of AI in writing stir the pot. Yet, Artprice by Artmarket stands out by anchoring creative freedom and responsibility in the spotlight. Grounded on an initiative launched...

Ericsson Executes Bold Share Buyback Plan in Oct.

Ericsson Kicks Off October with Major Share Repurchases Ericsson's taking bold steps in consolidating shareholder value, and folks, this ain't your run-of-the-mill stock-in-the-drawer move. Between October 19 and 23, 2026, Ericsson picked up 500,000 of its own Class B shares. Yep, you heard right—half a million shares just like that, with a neat price tag rounding out...

Coastal Financial Faces Lawsuit Amid Massive Stock Hit

Coastal Financial Corporation's (NASDAQ:CCB) recent nosedive is more distressing than a rollercoaster ride. After a 43.52% stock drop, investors are furious, to say the least. What tipped the scales? Coastal's financial revelations painted a bleak picture, but that’s just scratching the surface of a mess that has folks heading for legal battles. Behind the Numbers: The...

SUNON's Approach to AI-Driven Workspaces Debuted at ORGATEC

SUNON's Unique Spin on Future Workspaces The world of workplace solutions is buzzing with ideas on how to blend smart tech with soulful spaces. This year, SUNON is hitting ORGATEC 2026 in Cologne with a bold approach that stitches AI, nature, and circular design right into the fabric of office life. They’re not just setting up shop; they’re promising a peek into a...

Coastal Faces Legal Storm: Investors Eyeing the Clock

Coastal Financial in the Crosshairs The stakes are big, folks. Coastal Financial Corporation (NASDAQ: CCB) is caught in a storm, and it's not a gentle breeze. A securities class action has hit the table, and it's drawing in investors like seagulls to a beach picnic. What Lit the Match? The story kicks off with a plummet so dramatic it turned heads and wallets upside...

Decoding the Risks and Rewards of Older Homes

Cracking Open the Older Homes Enigma You've got these older homes—charm oozing out of every nook and cranny but potential pitfalls hidden beneath every surface. I'm talking about that irresistible lure of historic details that come with a side of risk. Now, before you jump in with both feet, you might want to pause and consider what Lee Malcom from Malcom & Malcom...

ASICS and University of Michigan Launch Innovation Lab

Running Innovation Gets a Boost in Ann Arbor On a crisp fall day up in Ann Arbor, ASICS and the University of Michigan have decided it's high time to shake up the world of running product R&D. These two powerhouses just launched the ASICSx Michigan Sport Innovation Center (AMSI), an academic-industry research lab. It's like they're mixing college smarts with business...

Bank of America Faces Class-Action Suit in Court

Mixed Bag for Bank of America Investors If you thought you could just park your cash in big banks and slumber through the financial year, think again. Bank of America (NYSE: BAC) has found itself in hot water with a securities fraud class-action suit looming over what some are calling a pretty nasty oversight in compliance. A 4.76% stock drop was a bitter sip for those...

Dar Global Eyes Dubai for Strategic Real Estate Moves

Tapping into Dubai's Real Estate Allure Every seasoned investor knows the real estate game ain't for the faint of heart, especially when you’re playing in a market as competitive as Dubai's. But here comes Dar Global Capital Partners (DGCP), throwing their hat into the ring with a fresh strategy centered around high-value real estate. Sure, they aren't new to the...